Markets › United States › NYSE › BIO-B

Bio-Rad Laboratories, Inc.

NYSE:BIO-BHealthcare

$364.15−0.25%At closeAt close · Wed 14 Oct · ≈ AED 1,337.34 · Market cap $9.55B · Next earnings Wed 4 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	56.5%	56.1%	55.9%	53.4%	53.7%	52.0%	—	—
Operating margin	16.6%	17.1%	17.2%	12.6%	10.5%	10.5%	10.5%	+0.0 pts
Net margin	149.8%	145.6%	−129.5%	−23.9%	−71.9%	29.4%	29.4%	+0.0 pts
EBITDA margin	199.5%	191.2%	−160.2%	−24.5%	−83.5%	48.4%	—	—
Return on equity	38.6%	31.1%	−37.7%	−7.3%	−28.1%	10.2%	10.2%	+0.0 pts
Return on assets	29.4%	23.9%	−26.9%	−5.2%	−19.7%	7.2%	7.2%	+0.0 pts
Return on capital employed	3.4%	2.9%	3.7%	2.9%	3.0%	2.7%	—	—
Debt / equity	0.0×	0.0×	0.1×	0.2×	0.2×	0.2×	0.2×	+0.0%
Debt / assets	1.7%	1.3%	10.3%	11.4%	14.7%	14.5%	—	—
Interest coverage	19.3×	322.6×	12.7×	6.8×	5.5×	5.5×	—	—
Current ratio	3.4×	2.9×	5.6×	5.8×	6.5×	5.6×	5.6×	+0.0%
Quick ratio	2.4×	2.1×	4.3×	4.3×	4.9×	4.2×	—	—
Cash ratio	1.0×	0.7×	0.8×	0.8×	1.0×	1.0×	1.0×	+0.0%
Asset turnover	0.2×	0.2×	0.2×	0.2×	0.3×	0.2×	—	—
Inventory turnover	1.8×	2.2×	1.7×	1.6×	1.6×	1.7×	—	—
Receivables turnover	6.1×	6.9×	5.7×	5.5×	5.7×	5.5×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—